1887

Abstract

The success of certain sequence types such as ST131 that produce CTX-M or NDM β-lactamases, and ST405 that produce CTX-M β-lactamases, among extraintestinal (ExPEC) had previously been linked to a combination of antimicrobial resistance and certain virulence factors. The adherence properties of these sequence types to gastro-intestinal epithelial cells had not been investigated. A study was therefore designed to investigate the phylogenetic groups, virulence factors and adherence properties of sequence types ST101, ST131 and ST405 that produce CTX-M-15 and NDM-1. Our results show that ST131 was positive for phylogenetic group B2, ST101 for B1 and ST404 for D. ST131 had more virulence factors than ST101 or ST405. Interestingly, ST101 adhered more avidly to HEp-2 and Caco-2 cells than did ST131 and ST405. Our study showed that adherence to gastro-intestinal cells did not seem to play an important role in the worldwide epidemiological success of ST131 and ST405. The exact role of ExPEC-associated virulence genes is unknown and it is unlikely that one set of factors determines the virulence properties and epidemiological success of certain sequence types. Future investigations should be undertaken to study the microbiological and ecological factors that make certain sequence types among ExPEC such successful pathogens.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.048983-0
2013-04-01
2024-12-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/4/525.html?itemId=/content/journal/jmm/10.1099/jmm.0.048983-0&mimeType=html&fmt=ahah

References

  1. CLSI 2012 Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute
  2. Coelho A., Mora A., Mamani R., López C., González-López J. J., Larrosa M. N., Quintero-Zarate J. N., Dahbi G., Herrera A. other authors 2011; Spread of Escherichia coli O25b : H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 66:517–526 [View Article][PubMed]
    [Google Scholar]
  3. Coque T. M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Cantón R., Nordmann P. 2008; Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14:195–200 [View Article][PubMed]
    [Google Scholar]
  4. Dobrindt U. 2005; (Patho-)genomics of Escherichia coli . Int J Med Microbiol 295:357–371 [View Article][PubMed]
    [Google Scholar]
  5. Hawser S. P., Bouchillon S. K., Hoban D. J., Badal R. E., Hsueh P. R., Paterson D. L. 2009; Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 53:3280–3284 [View Article][PubMed]
    [Google Scholar]
  6. Hyland R. M., Griener T. P., Mulvey G. L., Kitov P. I., Srivastava O. P., Marcato P., Armstrong G. D. 2006; Basis for N-acetyllactosamine-mediated inhibition of enteropathogenic Escherichia coli localized adherence. J Med Microbiol 55:669–675 [View Article][PubMed]
    [Google Scholar]
  7. Hyland R. M., Sun J., Griener T. P., Mulvey G. L., Klassen J. S., Donnenberg M. S., Armstrong G. D. 2008; The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin. Cell Microbiol 10:177–187[PubMed]
    [Google Scholar]
  8. Johnson J. R., Stell A. L. 2000; Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181:261–272 [View Article][PubMed]
    [Google Scholar]
  9. Johnson J. R., Menard M., Johnston B., Kuskowski M. A., Nichol K., Zhanel G. G. 2009; Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53:2733–2739 [View Article][PubMed]
    [Google Scholar]
  10. Johnson J. R., Johnston B., Clabots C., Kuskowski M. A., Castanheira M. 2010; Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51:286–294 [View Article][PubMed]
    [Google Scholar]
  11. Jones G. L., Warren R. E., Skidmore S. J., Davies V. A., Gibreel T., Upton M. 2008; Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases. J Antimicrob Chemother 62:1245–1251 [View Article][PubMed]
    [Google Scholar]
  12. Laupland K. B., Church D. L., Vidakovich J., Mucenski M., Pitout J. D. 2008; Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 57:441–448 [View Article][PubMed]
    [Google Scholar]
  13. Mihaila L., Wyplosz B., Clermont O., Garry L., Hipeaux M. C., Vittecoq D., Dussaix E., Denamur E., Branger C. 2010; Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone. J Antimicrob Chemother 65:1537–1539 [View Article][PubMed]
    [Google Scholar]
  14. Mora A., Blanco M., López C., Mamani R., Blanco J. E., Alonso M. P., García-Garrote F., Dahbi G., Herrera A. other authors 2011; Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 37:16–21 [View Article][PubMed]
    [Google Scholar]
  15. Mushtaq S., Irfan S., Sarma J. B., Doumith M., Pike R., Pitout J., Livermore D. M., Woodford N. 2011; Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother 66:2002–2005 [View Article][PubMed]
    [Google Scholar]
  16. Nordmann P., Poirel L., Walsh T. R., Livermore D. M. 2011; The emerging NDM carbapenemases. Trends Microbiol 19:588–595 [View Article][PubMed]
    [Google Scholar]
  17. Park C. H., Robicsek A., Jacoby G. A., Sahm D., Hooper D. C. 2006; Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50:3953–3955 [View Article][PubMed]
    [Google Scholar]
  18. Peirano G., Pitout J. D. 2010; Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35:316–321 [View Article][PubMed]
    [Google Scholar]
  19. Peirano G., Ahmed-Bentley J., Woodford N., Pitout J. D. 2011a; New Delhi metallo-beta-lactamase from traveler returning to Canada. Emerg Infect Dis 17:242–244 [View Article][PubMed]
    [Google Scholar]
  20. Peirano G., Schreckenberger P. C., Pitout J. D. 2011b; Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother 55:2986–2988 [View Article][PubMed]
    [Google Scholar]
  21. Peirano G., van der Bij A. K., Gregson D. B., Pitout J. D. 2012; Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J Clin Microbiol 50:294–299 [View Article][PubMed]
    [Google Scholar]
  22. Pitout J. D. 2012; Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 3:9[PubMed] [CrossRef]
    [Google Scholar]
  23. Pitout J. D., Laupland K. B. 2008; Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159–166 [View Article][PubMed]
    [Google Scholar]
  24. Pitout J. D., Nordmann P., Laupland K. B., Poirel L. 2005; Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56:52–59 [View Article][PubMed]
    [Google Scholar]
  25. Pitout J. D., Church D. L., Gregson D. B., Chow B. L., McCracken M., Mulvey M. R., Laupland K. B. 2007; Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 51:1281–1286 [View Article][PubMed]
    [Google Scholar]
  26. Pitout J. D., Campbell L., Church D. L., Gregson D. B., Laupland K. B. 2009; Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother 53:2539–2543 [View Article][PubMed]
    [Google Scholar]
  27. Poirel L., Lagrutta E., Taylor P., Pham J., Nordmann P. 2010; Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 54:4914–4916 [View Article][PubMed]
    [Google Scholar]
  28. Robicsek A., Strahilevitz J., Sahm D. F., Jacoby G. A., Hooper D. C. 2006; qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50:2872–2874 [View Article][PubMed]
    [Google Scholar]
  29. Russo T. A., Johnson J. R. 2003; Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5:449–456 [View Article][PubMed]
    [Google Scholar]
  30. Smet A., Martel A., Persoons D., Dewulf J., Heyndrickx M., Claeys G., Lontie M., Van Meensel B., Herman L. other authors 2010; Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 16:129–134 [View Article][PubMed]
    [Google Scholar]
  31. Sullivan C. B., Diggle M. A., Clarke S. C. 2005; Multilocus sequence typing: data analysis in clinical microbiology and public health. Mol Biotechnol 29:245–254 [View Article][PubMed]
    [Google Scholar]
  32. van der Bij A. K., Pitout J. D. 2012; The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 67:2090–2100 [View Article][PubMed]
    [Google Scholar]
  33. Van der Bij A. K., Peirano G., Pitondo-Silva A., Pitout J. D. 2012; The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn Microbiol Infect Dis 72:297–302 [View Article][PubMed]
    [Google Scholar]
  34. Yamane K., Wachino J., Suzuki S., Arakawa Y. 2008; Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 52:1564–1566 [View Article][PubMed]
    [Google Scholar]
  35. Yong D., Toleman M. A., Giske C. G., Cho H. S., Sundman K., Lee K., Walsh T. R. 2009; Characterization of a new metallo-beta-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054 [View Article][PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.048983-0
Loading
/content/journal/jmm/10.1099/jmm.0.048983-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error